Third Rock Ventures

7 stories
TACKLING SEVERE OBESITY
Zafgen completes $96 million IPO with big demand for shares
zafgen

Zafgen Inc. has completed its initial public offering amid strong demand from investors. The Cambridge biotech firm increased the size of the offering and sold shares at the top of its projected range on Wednesday, raising a total of $96 million. The IPO is the 10th by a Massachusetts-based biotech firm so far this year, topping the tally from last year of nine and setting a new record.

Read More

Top dollar
The 10 largest Boston VC deals of February
Mark Levin, a partner of Third Rock Ventures
Boston’s top venture capital hauls in February went to companies tackling Parkinson’s disease, cybersecurity, and personal health monitoring. Here are the 10 largest Boston-area VC deals I came across during the month. Read More